We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

177 hedge funds and large institutions have $1.63B invested in NEVRO CORP. in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1.52B → $1.63B (+$113M)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% more funds holding

Funds holding: 176177 (+1)

3% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 60

11% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $32.7M

Holders
177
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
3.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
58
Reduced
60
Closed
27
Calls
$29.1M
Puts
$32.7M
Net Calls
-$3.64M
Net Calls Change
-$3.33M
Name Holding Trade Value Shares
Change
Change in
Stake
CAPTRUST Financial Advisors
201
CAPTRUST Financial Advisors
North Carolina
-$15K -331 Closed
SPIA
202
Steward Partners Investment Advisory
New York
-$1K -31 Closed
C
203
Covestor
United Kingdom
-$46 -1 -25%
PA
204
Parallel Advisors
California
+$46 +1 +17%

NVRO Hedge Fund Activity: Q3 2022 in Review

177 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2022, worth a combined $1.63B — up 7.5% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NVRO positions and 27 closed out — a net gain of 1 holder — while 58 added to existing stakes and 60 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $150M. The largest seller was T. Rowe Price Associates, cutting an estimated $33.8M.

  • 177 institutional investors held NEVRO CORP. (NVRO) as of Q3 2022, up from 176 in Q2 2022.
  • Funds reported $1.63B of NEVRO CORP. stock for Q3 2022, up 7.5% quarter-over-quarter.
  • 28 funds opened new NEVRO CORP. positions in Q3 2022 and 27 closed out, a net change of +1 holder.
  • The largest NEVRO CORP. buyer in Q3 2022 was Fidelity Investments, an estimated $150M added.
  • The largest NEVRO CORP. seller in Q3 2022 was T. Rowe Price Associates, an estimated $33.8M sold.

Based on aggregated 13F filings for Q3 2022.